Skip to main content

Table 2 Univariate analyses of different prognostic factors in BC patients

From: RETRACTED ARTICLE: Expression of microRNA-497 and its prognostic significance in human breast cancer

 

Disease-free survival

Overall survival

Variables

HR (95% CI)

P-value

HR (95% CI)

P-value

Age (years)

1.341 (0.607-1.711)

0.316

1.503 (0.733-2.012)

0.618

Tumor size (cm)

2.278 (1.566-2.791)

0.008*

1.808 (1.127-2.443)

0.016*

Differentiation grade

2.334 (1.789-2.882)

0.022*

2.055 (1.726-3.404)

0.001*

Histological type

0.802 (0.477-1.682)

0.358

1.022 (0.799-1.501)

0.207

ER status

1.563 (0.815-1.921)

0.188

0.865 (0.699-1.118)

0.295

PR status

0.855 (0.429-1.277)

0.098

1.510 (0.719-2.121)

0.411

HER-2 status

1.777 (0.892-1.954)

0.301

1.221 (0.669-1.443)

0.189

Lymph node metastasis

3.122 (1.778-3.828)

0.017*

2.011 (1.548-2.817)

0.038*

Clinical stage

1.718 (1.150-2.203)

0.008*

1.823 (1.199-2.458)

0.014*

MiR-497 expression

2.340 (1.782-2.695)

0.005*

1.504 (1.285-1.914)

0.036*

  1. *P < 0. 05. Abbreviations: HR hazard ratio, 95% CI, 95% confidence interval, ER estrogen receptor, PR progesterone receptor, HER-2 c-erbB-2.